HUGE Mistake: White House MFN Drug Policy Will Devastate Innovation into New Treatments and Cures
November 20, 2020 As a leading advocate for consumers and patients across the country, CASE strongly condemns today’s new...
CASE Calls White House Drug Importation Plan Total Disaster for U.S. Consumers
September 28, 2020 In a move that can only be considered a total disaster for the safety and security...
CASE Statement Opposing President’s Order Embracing Pricing Index & Foreign Importation of Medications
Gerard Scimeca – Chairman, CASE July 24, 2020 As a strong voice for American patients and consumers, CASE urges...
More Socialized Medicine: CASE Opposes Dangerous Anti-Consumer Healthcare Proposal
June 29, 2020 As an advocate for consumers across the country, CASE urges House lawmakers to vote against H.R. 1425,...
Misguided “Buy American” Mandates Risk Catastrophic Consequences
June 22, 2020 As countries across the globe slowly begin the recovery from COVID-19,while also bracing for a possible second...
Trump Must Abandon Ill-Timed “Buy American” Drug Mandate
March 18, 2020 Prior to the interruptions caused due to the coronavirus, the Trump economy was surging. One of...
CASE Launches New Ad: Don’t Let HHS Put Insurer Interests Over Patient Savings
See Ad Here: February 19, 2020 If there is one goal Republicans and Democrats have in common these days,...
CASE Op-Ed – RealClear Markets: Nancy Pelosi’s Price Fixing Scheme Threatens Drug Innovation
Gerard Scimeca – Chairman, CASE January 7, 2020 Addressing sky-high healthcare costs is a pressing need in our country,...
Don’t Smoke ‘Em if You Got ‘Em – Pelosi Drug Pricing Bill is Like Two Pack-a-Day Habit
December 4, 2019 A new report issued this week by the President’s Council of Economic Advisers (CEA) provides a startling snapshot of...
Rep. Dan Crenshaw Breaks Down Why H.R.3 is a Dangerous Idea
“I don’t think people would be supportive of this idea if they realized there would be so many fewer cures.”...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/